BamSEC and AlphaSense Join Forces
Learn More

Xilio Therapeutics Inc. – Indentures

NASDAQ: XLO    
Share price (6/29/26): $9.27    
Market cap (6/29/26): $61.0 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.6
from S-3/A 8 pages Form of Subordinated Note
12/34/56
EX-4.5
from S-3/A 8 pages Form of Senior Note
12/34/56
EX-4.4
from S-3/A 63 pages Xilio Therapeutics, Inc. and Trustee Indenture Dated as of Subordinated Debt Securities
12/34/56
EX-4.3
from S-3/A 58 pages Section of Trust Indenture Act of 1939, as Amended Section of Indenture 310(a) 6.09 310(b) 6.08 6.10 310(c) Inapplicable 311(a) 6.13 311(b) 6.13 311(c) Inapplicable 312(a) 4.01 4.04 312(b) 4.04(c) 312(c) 4.04(c) 313(a) 4.03 313(b) 4.03 313(c) 4.03 313(d) 4.03 314(a) 4.02 314(b) Inapplicable 314(c) 2.04 8.04 9.01(c) 10.01(b) 11.05 314(d) Inapplicable 314(e) 11.05 314(f) Inapplicable 315(a) 6.01 6.02 315(b) 5.11 315(c) 6.01 315(d) 6.01 6.02 315(e) 5.12 316(a) 5.09 5.10 7.04 316(b) 5.06 5.10 316(c) 7.02 317(a) 5.04 317(b) 3.04 318(a) 11.07
12/34/56
EX-4.6
from S-3 8 pages Form of Subordinated Note
12/34/56
EX-4.5
from S-3 8 pages Form of Senior Note
12/34/56
EX-4.4
from S-3 63 pages Xilio Therapeutics, Inc. and Trustee Indenture Dated as of Subordinated Debt Securities
12/34/56
EX-4.3
from S-3 58 pages Section of Trust Indenture Act of 1939, as Amended Section of Indenture 310(a) 6.09 310(b) 6.08 6.10 310(c) Inapplicable 311(a) 6.13 311(b) 6.13 311(c) Inapplicable 312(a) 4.01 4.04 312(b) 4.04(c) 312(c) 4.04(c) 313(a) 4.03 313(b) 4.03 313(c) 4.03 313(d) 4.03 314(a) 4.02 314(b) Inapplicable 314(c) 2.04 8.04 9.01(c) 10.01(b) 11.05 314(d) Inapplicable 314(e) 11.05 314(f) Inapplicable 315(a) 6.01 6.02 315(b) 5.11 315(c) 6.01 315(d) 6.01 6.02 315(e) 5.12 316(a) 5.09 5.10 7.04 316(b) 5.06 5.10 316(c) 7.02 317(a) 5.04 317(b) 3.04 318(a) 11.07
12/34/56
EX-4.4
from 10-K 4 pages Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934, as Amended
12/34/56
EX-4.1
from 8-K 15 pages The Issuer Has Filed a Registration Statement (Including a Prospectus) With the Commission for the Offering to Which This Communication Relates. Before You Invest, You Should Read the Prospectus in That Registration Statement and Other Documents the Issuer Has Filed With the Commission for More Complete Information About the Issuer and This Offering. You May Get These Documents for Free by Visiting Edgar on the Commission Web Site at WWW.SEC.GOV. Xilio Therapeutics, Inc. Form of Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.2
from 8-K 20 pages Xilio Therapeutics, Inc. Form of Series [A]/[B]/[C] Warrant to Purchase Common Stock
12/34/56
EX-4.1
from 8-K 17 pages Xilio Therapeutics, Inc. Form of Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.6
from S-3 7 pages Form of Subordinated Note
12/34/56
EX-4.5
from S-3 7 pages Form of Senior Note
12/34/56
EX-4.4
from S-3 45 pages Xilio Therapeutics, Inc. and Trustee Indenture Dated as of Subordinated Debt Securities
12/34/56
EX-4.3
from S-3 41 pages Xilio Therapeutics, Inc. and Trustee Indenture Dated as of Senior Debt Securities
12/34/56
EX-4.1
from 8-K 12 pages Xilio Therapeutics, Inc. Form of Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.7
from S-3 8 pages Form of Subordinated Note
12/34/56
EX-4.6
from S-3 8 pages Form of Senior Note
12/34/56
EX-4.5
from S-3 61 pages Xilio Therapeutics, Inc. and Trustee Indenture Dated as of Subordinated Debt Securities
12/34/56